Cost outcome analysis of decentralized care for drug-resistant tuberculosis in Johannesburg, South Africa

By  Craig van Rensburg  Rebecca Berhanu  Kamban Hirasen  Dr. Denise Evans  Professor Sydney Rosen  Dr. Lawrence Long  |  | 

Drug resistant-tuberculosis is a growing burden on the South African health care budget. In response the National Department of Health implemented two important strategies in 2011; universal access to drug-sensitivity testing for rifampicin with Xpert MTB/RIF as the first-line diagnostic test for TB; and decentralization of treatment for RR/MDR-TB to improve access and reduce costs of treatment.

Publication details